Pirenzepine in duodenal ulcer. A multicentre double-blind controlled clinical trial. Second of two parts.
Barbara L, Belsasso E, Bianchi Porro G, +10 more·Scandinavian journal of gastroenterology. Supplement
Ninety-six patients with endoscopically proved active duodenal ulcers were admitted to a multicentre double-blind trial with either pirenzepine (100 mg/day, 25 mg in the morning and midday and 50 mg at bed time) or placebo for 4 weeks. Ninety-two patients (46 in each group) completed the trial. After 4 weeks, complete…